MedTrace Logo

High Intensity Ultrasound for the Treatment of Upper Inner Arm Skin Laxity

NCT05355714 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-05-02

No results posted yet for this study

Summary

Upper inner arms of enrolled subjects will be randomized to two (2) treatment groups: Sofwave and Ultherapy, with subjects receiving treatment with one device on their right side and the other on their left.

Conditions

  • Skin Laxity

Interventions

DEVICE

Sofwave

High-Frequency Non-Focused Ultrasound Device

DEVICE

Ultherapy

Microfocused Ultrasound with Visualization

Sponsors & Collaborators

  • Sofwave Medical LTD

    collaborator INDUSTRY

  • Goldman, Butterwick, Fitzpatrick and Groff

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-14
Primary Completion
2023-04-30
Completion
2023-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05355714 on ClinicalTrials.gov